Noradrenaline uptake mechanisms in human atrium.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001665:Binding Sites; D002462:Cell Membrane / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008680:Metaraminol / Q000378:metabolism; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors; D013012:Sorbitol / Q000378:metabolism; D014316:Tritium
D003984:Dibenzazepines; D006892:Hydroxydopamines; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D014316:Tritium; D013012:Sorbitol; D008680:Metaraminol; D012110:Reserpine; D007099:Imipramine; D009526:Nialamide; D003891:Desipramine; D002746:Chlorpromazine; D009638:Norepinephrine